There are 827 papers on hypercholesterolemia in aging research: 112 trials and 472 observational studies in people, 76 in animals, 143 reviews.
118 new papers in 30 daysSee all 1,160 papers on hypercholesterolemia
“high cholesterol (2.48 [2.44 -2.53]), and moderate obesity (2.19 [2.15 -2.23]) were the strongest risk factor determinants of multimorbidity”
- Human trial112
- Humans472
- Animals76
- In silico10
Interventions
7Caloric restriction
downin rats2
2 studies
Caloric restriction
downin rats2
Caloric restriction decreases hypercholesterolemia in rats (compared to CAF).
“Both CAFR alone and in combination with exercise reduced abdominal adiposity and hypercholesterolemia compared to CAF.”
Animalscompared to CAFmales
Scientific reports
Caloric restriction decreases hypercholesterolemia in rats (genetically obese rats).
“the hypercholesterolemia was reduced.”
Animalsgenetically obese rats
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Cholecalciferol
no changein humans1HR 1.05
1 study
Cholecalciferol
no changein humans1HR 1.05
Cholecalciferol showed no clear effect on hypercholesterolemia in humans (HR 1.05; 95% CI 0.97 to 1.13).
“hypercholesterolemia (HR 1.05; 95% CI 0.97 to 1.13)”
Human trialoral60,000 international units monthly4.6 yearsn = 12,126
Nutrients
Food insecurity
no changein humans1OR 1
1 study
Food insecurity
no changein humans1OR 1
Food insecurity was not clearly linked with hypercholesterolemia in humans (OR 1.00, p = 0.998).
“but not with high cholesterol (OR 1.00; p = 0.998)”
Humans
AHA Scientific Sessions 2025 abstract
Light at night
no changein humans1
1 study
Light at night
no changein humans1
Light at night was not clearly linked with hypercholesterolemia in humans.
“and hypertension (OR 1.74 [1.21-2.52]) but not with hypercholesterolemia.”
Humansn = 552
Light at night in older age is associated with obesity, diabetes, and hypertension
Sleep
Valeric acid
downin mice1
1 study
Valeric acid
downin mice1
Valeric acid decreases hypercholesterolemia in mice.
“valeric acid and caproic acid alone can activate the AMPK and ameliorate hypercholesterolemia”
Animalsin mice
Frontiers in nutrition
Helper-dependent adenoviral vector containing apoe
downin mice1
1 study
Helper-dependent adenoviral vector containing apoe
downin mice1
Helper-dependent adenoviral vector containing apoe prevents hypercholesterolemia in apoE-deficient mice.
“A single i.v. injection of this vector completely and stably corrected the hypercholesterolemia in apoE-deficient mice, an effect that lasted the natural lifespan of the mice.”
Animalsin apoE-deficient mice
Proceedings of the National Academy of Sciences of the United States of America
Growth hormone
downin rats1
1 study
Growth hormone
downin rats1
Growth hormone decreases hypercholesterolemia in rats (age-related hypercholesterolemia).
“However, GH treatment strongly reduced the hypercholesterolemia in 18-month-old animals.”
Animalsage-related hypercholesterolemiamales
Arteriosclerosis, thrombosis, and vascular biology
Effects
15Cognitive function
downin humans2no changein humans1
3 studies
Cognitive function
downin humans2no changein humans1
Hypercholesterolemia is linked with worse cognitive function in humans (comparable to being 8 to 10 years older).
“Associations of history of high cholesterol or heart attack on rate of cognitive decline, for example, were comparable to being 8 to 10 years older.”
Humans
Alzheimer's & dementia : the journal of the Alzheimer's Association
Hypercholesterolemia was not clearly linked with cognitive function in patients with stage 2 hypertension.
“Nevertheless, no significant differences were found in the mean scores between hypertensive patients with and without hypercholesterolemia.”
Humansin patients with stage 2 hypertension
Journal of hypertension
Hypercholesterolemia is linked with worse cognitive function in humans (comparable to being 11-12 years older).
“associations of history of high cholesterol or heart attack on rate of cognitive decline, for example, were comparable to being 11-12 years older.”
Humansup to 6.4 yearsn = 6,168
medRxiv : the preprint server for health sciencesPreprint
Extracellular matrix deposition
upin mice1
1 study
Extracellular matrix deposition
upin mice1
Hypercholesterolemia increases extracellular matrix deposition in mice.
“HyperC upregulated ECM deposition in SMCs”
Animalsaortic smooth muscle cell
Aging shifts artery cell gene activity in high-cholesterol mice
AHA Scientific Sessions 2026 abstract
Smooth muscle cell-to-fibromyocyte switch
is required forin mice1
1 study
Smooth muscle cell-to-fibromyocyte switch
is required forin mice1
Hypercholesterolemia is required for smooth muscle cell-to-fibromyocyte switch in mice.
“indicating that the SMC-to-fibromyocyte switch specifically requires HyperC.”
Animalsaorta
Aging shifts artery cell gene activity in high-cholesterol mice
AHA Scientific Sessions 2026 abstract
Visuoconstructional memory
downin humans1
1 study
Visuoconstructional memory
downin humans1
Hypercholesterolemia is linked with worse visuoconstructional memory in humans (weighted analysis (target population)) (b=-1.63±0.64, p=0.01).
“weighted analyses in the target population revealed associations between hypercholesterolemia and poorer visuoconstructional memory (b=‐1.63±0.64, p =0.01)”
Humansweighted analysis (target population)
Cardiovascular Risk Factors and Cognitive Function ‐ Generalizing Results from a Clinical Cohort
AAIC 2025 abstract
Mortality
downin humans1OR 0.6
1 study
Mortality
downin humans1OR 0.6
Hypercholesterolemia is linked with lower mortality in humans (mild hypercholesterolemia (LDL-C ≥ 130 mg/dL) compared to normal cholesterol) (OR 0.600, 95%CI 0.405-0.891).
“Cox regression analysis revealed a significant reduction in the hazard ratio (HR) for mortality in participants with mild hypercholesterolemia (LDL-C ≥ 130 mg/dL) compared to that in those with normal cholesterol”
Humansmild hypercholesterolemia (LDL-C ≥ 130 mg/dL) compared to normal cholesterol2018 to December 2024n = 168
The Cholesterol Paradox in Long-Livers from a Sardinia Longevity Hot Spot (Blue Zone)
Nutrients
Lifespan
upin humans1
1 study
Lifespan
upin humans1
Hypercholesterolemia is linked with longer lifespan in humans (LDL-C above 130 mg/dL compared to LDL-C lower than 130 mg/dL) (3.82 ± 1.88 years vs. 2.79 ± 1.56 years, p < 0.0001).
“Survival time was significantly longer in participants with LDL cholesterol (LDL-C) above 130 mg/dL compared to that in nonagenarians with LDL-C lower than 130 mg/dL (3.82 ± 1.88 years vs. 2.79 ± 1.56 years, p < 0.0001).”
HumansLDL-C above 130 mg/dL compared to LDL-C lower than 130 mg/dL2018 to December 2024n = 168
The Cholesterol Paradox in Long-Livers from a Sardinia Longevity Hot Spot (Blue Zone)
Nutrients
Trigeminal function
downin humans1
1 study
Trigeminal function
downin humans1
Hypercholesterolemia is linked with worse trigeminal function in humans (aging adults) (57.7% ± 17.1 vs. 74.1% ± 10.4, p = .008).
“Hypercholesterolemia was associated with psychophysical trigeminal dysfunction (mean lateralization performance in hypercholesterolemia 57.7% ± 17.1 vs. 74.1% ± 10.4, p = .008).”
Humansaging adultsn = 28
Intranasal Trigeminal Function in Aging Adults
American journal of rhinology & allergy
Cognitive decline
mediatesin humans1
1 study
Cognitive decline
mediatesin humans1
Hypercholesterolemia is linked with cognitive decline in humans (between SOM clusters and CFI) (up to 5 %).
“high cholesterol up to 5 %.”
Humansbetween SOM clusters and CFIn = 14,390
The Science of the total environment
LOX+ fibroblasts
upin mice1
1 study
LOX+ fibroblasts
upin mice1
Hypercholesterolemia increases LOX+ fibroblasts in mildly hypercholesterolaemic LDLR KO mice on chow.
“The expansion of collagen-related CXCL14+ and LOX+ fibroblasts in aged and hypercholesterolaemic aortic adventitia, respectively, coincided with increased adventitial collagen.”
Animalsin mildly hypercholesterolaemic LDLR KO mice on chowaorta
Cardiovascular research
Life expectancy
downin humans1HR 1.1
1 study
Life expectancy
downin humans1HR 1.1
Hypercholesterolemia is linked with lower life expectancy in humans (HR=1.10, loss of 1.0 years).
“high cholesterol (HR=1.10), hypertension (HR=1.48) or diabetes (HR=2.02) can be converted into a loss of 1.0, 4.4, and 8.9 years in life expectancy, respectively.”
Humans
Converting health risks into loss of life years - a paradigm shift in clinical risk communication
Aging
All 15Fewer
Upstream
2Oxidative stress and ROS signaling
mediatesin humans1
1 study
Oxidative stress and ROS signaling
mediatesin humans1
Oxidative stress and ROS signaling is linked with hypercholesterolemia in humans (6.5%).
“8-OHdG mediated 6.5% and 13.0% of the overall effect of the examined chemicals on hypercholesterolemia and hyper-LDL-cholesterolemia, respectively (all P < 0.05).”
Humansn = 486
Environmental research
Obesity
upin mice1
1 study
Obesity
upin mice1
Obesity induces hypercholesterolemia in mice (leptin-deficient ob/ob background compared with wild-type).
“Compared to the wild-type mice, all three obese background mice, namely ob/ob, ob/ob-klotho(-/-), and ob/ob-1α(OH)ase(-/-) mice developed hypercholesterolemia.”
Animalsleptin-deficient ob/ob background compared with wild-type
Biochemical and biophysical research communications
Associations
74Cardiovascular disease
upin humans4OR 2.99
4 studies
Cardiovascular disease
upin humans4OR 2.99
Hypercholesterolemia is linked with a higher risk of cardiovascular disease in people living with HIV (aOR 3.03, 95% CI 1.68-4.86, p = 0.005).
“hypercholesterolemia [aOR 3.03, 95% CI (1.68-4.86), p = 0.005]”
Humansin people living with HIV
Predictors of cardiovascular disease among people living with HIV in northern Nigeria
Research squarePreprint
Hypercholesterolemia predicts cardiovascular disease in humans (Fully adjusted model).
“The fully adjusted model revealed that history of diabetes and hypercholesterolemia were significant predictors for the 20-year-CVD events.”
HumansFully adjusted model20 yearsfemalesn = 1,001
Twenty-year cardiovascular disease incidence in menopausal women: insights from the ATTICA study
Climacteric : the journal of the International Menopause Society
Hypercholesterolemia is linked with a higher risk of cardiovascular disease in humans (OR 2.99 (95% CI 1.860-4.812)).
“hypercholesterolemia (OR 2.99 [95% CI 1.860-4.812], p < 0.001)”
Humans
Vascular health and risk management
Hypercholesterolemia is associated with cardiovascular disease in humans (aOR 1.70, 95% CI 1.07-2.69).
“hypercholesterolemia (aOR women:1.70; 95% CI 1.07-2.69, men 3.55; 95% CI 2.66-4.74)”
Humansfemales
Indian heart journal
Hypertension
upin humans4OR 1.64
4 studies
Hypertension
upin humans4OR 1.64
Hypercholesterolemia is associated with hypertension in humans (p<0.01).
“elderly age (p<0.01) and hypercholesterolemia (p<0.01), were significantly associated with hypertension.”
Humansn = 246
International Journal of Community Medicine and Public Health
Hypercholesterolemia is linked with a higher risk of hypertension in humans (compared to normal blood cholesterol levels) (AOR = 1.84; 95% CI 1.32, 2.57).
“Borderline (AOR = 2.0; 95% CI 1.05, 3.81) and high cholesterol levels (AOR = 1.84; 95% CI 1.32, 2.57) were associated with an increased odds of hypertension”
Humanscompared to normal blood cholesterol levels
Determinants of hypertension among Bhutanese adults: evidence from a national WHO STEPS survey
Scientific reports
Hypercholesterolemia is associated with hypertension in humans (AOR 4.09, 95% CI 3.56-4.71).
“Strong associations were also observed with hypercholesterolemia (AOR 4.09, 3.56-4.71), heart disease (AOR 3.54, 2.84-4.42), and diabetes (AOR 2.64, 2.28-3.05).”
Humans
Profiling individuals living with hypertension in Saudi Arabia 2021: a nationwide descriptive study
Frontiers in cardiovascular medicine
Hypercholesterolemia is associated with hypertension in humans (OR 1.64, 95% CI 1.12-2.40, p = 0.011).
“hypercholesterolemia (OR 1.64 95% CI 1.12-2.40 p-value 0.011) were significant factors favoring hypertension in the young adults.”
Humansn = 1,221
Frontiers in cardiovascular medicine
Diabetes mellitus
upin humans3OR 2.88
3 studies
Diabetes mellitus
upin humans3OR 2.88
Diabetes mellitus is associated with hypercholesterolemia in humans (OR 2.88; p=0.001).
“Diabetes was also significantly associated with hypertension (OR=3.02) and hypercholesterolemia (OR=2.88; both p=0.001).”
Humansn = 262
Chronic Disease Risk Factors Among Adults in Relizane, Algeria: A Comprehensive Study
Al-Rafidain Journal of Medical Sciences
Hypercholesterolemia is associated with diabetes mellitus in humans.
“the Poisson model showed a direct association between DM and female sex, age >60 years, no formal education, physical inactivity during leisure time, self-reported hypercholesterolemia and hypertension, overweight, and obesity.”
Humans
Ciencia & saude coletiva
Diabetes mellitus is associated with hypercholesterolemia in humans (PR: 1.54; 95% CI: 1.04-2.29).
“those with diabetes mellitus (PR: 1.54; 95% CI: 1.04-2.29)”
Humansn = 232
Factors associated with hypercholesterolemia in older adults: A cross-sectional investigation
Aging medicine (Milton (N.S.W))
Age
upin humans2OR 10.198
2 studies
Age
upin humans2OR 10.198
Age is linked with a higher risk of hypercholesterolemia in humans (OR 10.198, 95% CI 4.481–23.208).
“The odds of developing hypercholesterolemia increased with age 10.6-fold in men (OR=10.198, 95% CI: 4.481-23.208, p<0.001)”
Humansmales
Siberian Journal of Life Sciences and Agriculture
Age is associated with hypercholesterolemia in humans (urban residents in China) (2.2% at ages 18–29 versus 10.3% in aged 70 group).
“The minimum prevalence of hypercholesterolemia was in aged 18 to 29 group and maximum in aged 70 group”
Humansurban residents in Chinan = 54,042
Serum total cholesterol status among urban residents aged 18 and above in China from 2010 to 2012
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Cognitive impairment
upin humans2+10% increaseOR 3.558
2 studies
Cognitive impairment
upin humans2+10% increaseOR 3.558
Hypercholesterolemia is associated with cognitive impairment in humans (addition of hypercholesterolemia to diabetes, hypertension, and obesity) (10% increase).
“With the addition of hypercholesterolemia, this increase reached 10%.”
Humansaddition of hypercholesterolemia to diabetes, hypertension, and obesityn = 6,449
Association of diabetes, hypertension and obesity with cognitive impairment in adults
Dementia & neuropsychologia
Hypercholesterolemia is linked with a higher risk of cognitive impairment in humans (OR = 3.558, p = 0.018).
“the diagnosis of hypercholesterolemia (OR = 3.558, p = 0.018) significantly increased the odds of cognitive impairment”
Humansn = 166
Research SquarePreprint
Mild cognitive impairment
upin humans2OR 6.67
2 studies
Mild cognitive impairment
upin humans2OR 6.67
Hypercholesterolemia is linked with a higher risk of mild cognitive impairment in subjective cognitive decline (adjusted OR 6.67, p ≤ 0.05).
“hypercholesterolemia (adjusted odds ratio: 6.67) were risk factors for progression in SCD, p ≤ 0.05”
Humansin subjective cognitive decline
Risk factors and cognitive domain markers of progression in subjective cognitive decline
Journal of Alzheimer's disease : JAD
Hypercholesterolemia is associated with mild cognitive impairment in humans (Non-Hispanic White participants).
“For NHW females, diabetes, hypertension, and hypercholesterolemia were significantly associated with increased MCI.”
HumansNon-Hispanic White participantsfemales
Alzheimer's & dementia : the journal of the Alzheimer's Association
Female sex
upin humans2
2 studies
Female sex
upin humans2
Female sex is associated with hypercholesterolemia in humans (63.5-66.9%).
“Elevated cholesterol affected 63.5-66.9% of participants, especially women (p <0.001), with no age-related decline (p for trend < 0.05).”
Humans
Frontiers in public health
Female sex is associated with hypercholesterolemia in humans (PR: 1.94; 95% CI: 1.27-2.97).
“a higher probability of hypercholesterolemia was observed in women (PR: 1.94; 95% CI: 1.27-2.97)”
Humansn = 232
Factors associated with hypercholesterolemia in older adults: A cross-sectional investigation
Aging medicine (Milton (N.S.W))
Dementia
upin humans1downin humans1
2 studies
Dementia
upin humans1downin humans1
Hypercholesterolemia is linked with a higher risk of dementia in humans (aOR = 3.25).
“Hypercholesterolemia (aOR = 3.25, p > 0.001), stroke (aOR = 1.43, p = 0.015), and carotid stenosis (aOR = 2.23, p > 0.001) were significantly associated with risk of dementia”
Humansn = 1,298
Atherosclerosis and dementia development: an epidemiological case-control study
Central European journal of public health
Hypercholesterolemia is linked with a lower risk of dementia in humans after controlling for factors other than stroke-related factors.
“hypercholesterolemia was correlated with a relatively low risk of all-cause incident dementia”
Humansafter controlling for factors other than stroke-related factorsn = 1,285
Therapeutic advances in chronic disease
Chronic kidney disease
upin humans2
2 studies
Chronic kidney disease
upin humans2
Hypercholesterolemia is linked with a higher risk of chronic kidney disease in humans (type-II diabetes mellitus) (AHR 3.31, 95% CI 1.3323-8.2703).
“Having cardiovascular disease/s [AHR = 3.82; 95%CI: 1.4470-10.1023] and hypercholesterolemia [AHR = 3.31; 95% CI: 1.3323-8.2703] were predictors of chronic kidney disease.”
Humanstype-II diabetes mellitus
PloS one
Hypercholesterolemia is associated with chronic kidney disease in humans (Community population in Shanghai, China).
“The risk factors for CKD are age, female, hyperuricemia, cardiovascular disease, hypertension, hypercholesterolemia, and smoking.”
HumansCommunity population in Shanghai, Chinan = 24,886
Community-based study on elderly CKD subjects and the associated risk factors
Renal failure
PGS-LDL
upin humans1
1 study
PGS-LDL
upin humans1
PGS-LDL is associated with hypercholesterolemia in humans (Healthy low-carbohydrate diet) (OR per 1-SD, 2.27; 95% CI, 1.18-4.81).
“and new hypercholesterolemia (OR per 1-SD, 2.27; 95% CI, 1.18-4.81).”
HumansHealthy low-carbohydrate diet6 monthsn = 223
medRxivPreprint
All 74Fewer
Trial sponsors
Company75 trialsPhase 456,206 people
Company31 trialsPhase 413,725 people
Company22 trialsPhase 440,922 people
Company12 trialsPhase 45,264 people
Company10 trialsPhase 44,821 people
Novartis Pharmaceuticals Corporation
Company9 trialsPhase 43,918 people
Company8 trialsPhase 44,801 people
Company7 trialsPhase 41,048 people
Funding
17 grants since 2016National Heart, Lung, and Blood Institute$10.9MEuropean Commission€7.3MJapan Society for the Promotion of Science¥4.2M
Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH)
National Heart, Lung, and Blood InstituteGeisinger Clinic$722K2022–2027
National Heart, Lung, and Blood InstituteUniversity of California-irvine$236K2026–2028
National Heart, Lung, and Blood InstituteClemson University$624K2024–2028
IMPLEMENTING MULTICOMPONENT INTERVENTIONS TO TREAT BLOOD DONORS WITH FAMILIAL HYPERCHOLESTEROLEMIA
National Heart, Lung, and Blood InstituteUT Southwestern Medical Center$502K2022–2027
National Heart, Lung, and Blood InstituteNorthwestern University$516K2022–2027
Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH
National Heart, Lung, and Blood InstituteGeisinger Clinic$726K2022–2027
European CommissionAssociação para Investigação e Desenvolvimento da Faculdade de Medicina€7.3M2025–2028
Role of new lipid biomarkers in severe hypercholesterolemia
Swiss National Science FoundationUniversity of LausanneCHF 480K2024–2028
National Heart, Lung, and Blood InstituteBoston Children's Hospital$170K2019–2025
National Heart, Lung, and Blood InstituteUniversity of Pennsylvania$392K2022–2023